It is time for “The M&A Daily” and we have what might normally appear as a red flag alert here today. Yesterday’s news that Sanofi-Aventis SA (NYSE: SNY) was borrowing $7 billion via…
Jon C. Ogg It has finally happened. Genzyme Corporation (NASDAQ: GENZ) is being acquired by Sanofi-Aventis (NYSE: SNY). The deal should trade at a premium to the $74.00 cash component due to what is called…
Jon C. Ogg Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) is out with the new portfolio holdings as of December 31, 2010, so these are his new 2011 investments. There were many changes in the prior…
They call it “Merger Monday” for a reason. Today’s news is not dominated by football hangovers. It is dominated by a slew of headlines over mergers, mergers, and more mergers. We compiled…
Genzyme Corporation (NASDAQ: GENZ) is getting closer to capitulating to the offer to be acquired by Sanofi-Aventis (NYSE: SNY). At issue this morning is that Genzyme has agreed to open its books…
Jon C. Ogg Investors have tried for years to follow the strategy of Warren Buffett, considered by many to be the greatest investor in history. That’s ironic given how little he seems to care about…
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) has shown its latest holdings as of the close on September 30, 2010. The changes were big on the first two lists but more static on…
The Sanofi-Aventis (NYSE: SNY) acquisition attempt of Genzyme Corp. (NASDAQ: GENZ) is taking a turn in a strange direction. The company is holding out for more than the $69.00 cash offer on…
Jon C. Ogg The proposed merger and acquisition of Genzyme Corporation (NASDAQ: GENZ) by Sanofi-Aventis (NYSE: SNY) is about to get interesting. There is a building collective thought that a higher bid price than $69.00…
Jon C. Ogg A lot of companies are working on developing microbes to eat something ordinary and expel something extraordinary, like diesel fuel or methane or butanol. Laboratory scale projects have all proved the feasibility…
Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there has been on a single day in months and months. The news…
The cast of characters in this week’s Unusual Suspects is not any ordinary group of companies. There are many key stocks to watch for investors that have carryover issues from last week…
Reuters: The Bank of Japan eased policy to fight a rise in the yen. Reuters: Obama said the economy is not growing fast enough. Reuters: Intel (NASDAQ: INTC) will buy Infineon’s mobile…
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) has shown its latest holdings as of the close on June 30, 2010. These have been broken down into 3 groups of ‘A to G’ and…
Genzyme Corporation (NASDAQ: GENZ) still has an incredible merger ‘deal premium’ associated with it over a pending Sanofi-Aventis (NYSE: SNY) buyout. Genzyme’s troubles have left it vulnerable to a deal for a…
